EPCAM and hepatocellular carcinoma: In HCC, EpCAM emerged as an important CSC surface marker and EpCAM+ cells correlate with worse prognosis and possess CSC-like properties showing tumor-initiating capabilities with as few as 200 cells in a nude mouse model [11, 14–17].